Literature DB >> 17501624

Bone remodeling rate and remodeling balance are not co-regulated in adulthood: implications for the use of activation frequency as an index of remodeling rate.

Juliet E Compston1, Shobna Vedi, Stephen Kaptoge, Ego Seeman.   

Abstract

UNLABELLED: Use of activation frequency as a measure of remodeling rate assumes co-regulation of remodeling rate and remodeling balance. In iliac crest biopsy specimens from 57 healthy subjects 19-80 yr of age, no correlations were shown between these variables, an observation that challenges the use of activation frequency as an estimate of remodeling rate.
INTRODUCTION: The histomorphometric derivation of activation frequency assumes that the remodeling rate is dependent on the duration of the remodeling cycle and the amount of bone formed in individual remodeling units. This implies that remodeling balance and remodeling rate are co-regulated. We tested this assumption in normal human adult cancellous bone.
MATERIALS AND METHODS: Relationships between indices of bone formation at the basic multicellular unit (BMU) level (wall width and mineral apposition rate) and indices of remodeling rate (mineralizing perimeter and osteoid perimeter) were examined in iliac crest biopsies obtained from 57 healthy adults (24 men) 19-80 yr of age.
RESULTS: Univariate analysis revealed a negative correlation between wall width and osteoid perimeter (r = -0.38; p = 0.0004), but there was no correlation between wall width and mineralizing perimeter or between mineral apposition rate and either mineralizing or osteoid perimeter. After adjustment for age and sex, the association between wall width and osteoid perimeter was no longer observed. Both wall width and mineral apposition rate correlated negatively with age (r = -0.75, p < 0.0001 and r = -0.27, p = 0.05, respectively).
CONCLUSIONS: Our results indicate that remodeling balance and remodeling rate are not co-regulated in adult human bone. Activation frequency, as currently derived from histomorphometric variables, may therefore be unreliable as an indicator of remodeling rate.

Entities:  

Mesh:

Year:  2007        PMID: 17501624     DOI: 10.1359/jbmr.070407

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  9 in total

1.  Bone matrix mineralization is preserved during early perimenopausal stage in healthy women: a paired biopsy study.

Authors:  B M Misof; P Roschger; S Blouin; R Recker; K Klaushofer
Journal:  Osteoporos Int       Date:  2015-12-09       Impact factor: 4.507

2.  Histomorphometric interpretation of bone biopsies for the evaluation of osteoporosis treatment.

Authors:  Juliet E Compston
Journal:  Bonekey Rep       Date:  2012-04-04

3.  Progression of bone ingrowth and attachment strength for stability of percutaneous osseointegrated prostheses.

Authors:  Sujee Jeyapalina; J Peter Beck; Roy D Bloebaum; Kent N Bachus
Journal:  Clin Orthop Relat Res       Date:  2014-10       Impact factor: 4.176

Review 4.  Over-suppression of bone turnover: does it exist?

Authors:  Juliet Compston
Journal:  Curr Osteoporos Rep       Date:  2007-12       Impact factor: 5.096

5.  Factors associated with osteocalcin in men with spinal cord injury: findings from the FRASCI study.

Authors:  Ricardo A Battaglino; Nguyen Nguyen; Megan Summers; Leslie R Morse
Journal:  Spinal Cord       Date:  2019-07-12       Impact factor: 2.772

Review 6.  Osteoporosis primer for the vertebroplasty practitioner: expanding the focus beyond needles and cement.

Authors:  A E Kearns; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2008-09-03       Impact factor: 3.825

Review 7.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

Authors:  Ann E Kearns; Sundeep Khosla; Paul J Kostenuik
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

Review 8.  Teriparatide for osteoporosis: importance of the full course.

Authors:  R Lindsay; J H Krege; F Marin; L Jin; J J Stepan
Journal:  Osteoporos Int       Date:  2016-02-22       Impact factor: 4.507

Review 9.  Bone Diseases in Patients with Chronic Liver Disease.

Authors:  Hae Min Jeong; Dong Joon Kim
Journal:  Int J Mol Sci       Date:  2019-08-31       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.